Inhibitor Therapeutics, Inc. — Key Metrics
9 years of history · ending 2021-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-0
Book Value Per Share
$-0
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity↑+150.3pts
8.6%
Return on Assets↓-187.6pts
-313.5%
Return on Invested Capital↑+119.8pts
7.4%
Current Ratio↓-92.1% -$1
0.09
Quick Ratio↓-92.1% -$1
0.09
Asset Turnover
0.00
R&D / Revenue
18775.0%
SBC / Revenue
3871.8%
Working Capital↓-1243.8% -$675K
$-621K
Net Current Asset Value↓-6770.8% -$4M
$-4M
Invested Capital↓-2273.9% -$4M
$-4M
OCF / Net Income↑+29.3% +$0
0.74
FCF / Net Income↑+29.3% +$0
0.74
Accruals Ratio (Sloan)↑+151.9pts
-133.0%
Net Debt↑+91.1% +$313K
$-31K
Net Debt / EBITDA↑+40.0% +$0
0.09
Interest Coverage
-21.93
Cash Coverage
-14.86
Dividend Coverage
-27.28
Tangible Common Equity↓-2273.9% -$4M
$-4M
TCE / Total Assets↓-6181.3pts
-6159.6%
NOPAT↑+93.6% +$4M
$-257K
Cash ROIC↑+87.3pts
6.3%
WC / Revenue
3203.5%
Reinvestment Rate
0.0%
Total Payout Ratio
0.0%
Asset Growth vs Revenue Growth
73.0%
Book Value 5Y CAGR
—
Stock Price (FY-end)↓-40.2% -$0
$0
Market Cap
$56M
P/E Ratio
—
P/B Ratio
—
P/TB Ratio
—
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$56M
EV / FCF
—
FCF Yield
-0.4%
Shareholder Yield
-0.1%
R&D Yield
0.0%
Graham Number
—
Shares Variation (YoY)
1997.2%
Beta (5Y)↑+215.0% +$1
0.38
Cost of Equity↑+3.5pts
6.4%
52W High↓-31.9% -$0
$0
52W Low↓-86.5% -$0
$0
Trailing Return 1Y↑+364.2pts
328.6%
Trailing Return 5Y
-61.5%
F-Score (Piotroski)↑+100.0% +$1
2.00
Z-Score (Altman)
-1395.23
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.